NCT03422978View on ClinicalTrials.gov

The Effects of Dexmedetomidine on Intravenous Anesthetic Requirements for Children Undergoing Dental Procedures

PHASE4CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

March 14, 2018

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2021

Conditions
Anesthetic Sparing
Interventions
DRUG

Dexmedetomidine

Single dose dexmedetomidine administered over 60 seconds post-induction.

DRUG

Normal saline

Single dose normal saline administered over 60 seconds post-induction.

Trial Locations (1)

V5Z 4V4

BC Children's Hospital - Department of Anesthesia, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT03422978 - The Effects of Dexmedetomidine on Intravenous Anesthetic Requirements for Children Undergoing Dental Procedures | Biotech Hunter | Biotech Hunter